India's Covid vaccine 'Covaxin' will be 60% effective, says Bharat Biotech

Sunday, 22 Nov, 2.51 pm

COVID-19 vaccine 'Covaxin' will be at least 60 per cent effective, vaccine developer Bharat Biotech has said.

Sai D Prasad, President of Quality Operations at Bharat Biotech, told India Today that the company is aiming to launch the vaccine in the second quarter of 2021.

Noting that the phase 3 efficacy data of 'Covaxin' will be available by the end of quarter 1 of 2021, Prasad said that the chances of the "vaccine being less than 50 per cent effective are remote".

"The WHO, US FDA [Food and Drug Administration] and even India's Central Drugs Standard Control Organisation (CDSCO) approve a respiratory vaccine if it achieves 50 per cent efficacy.